Enterics for Global Health (EFGH)

NCT06047821 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 9800

Last updated 2025-01-14

No results posted yet for this study

Summary

Diarrhea remains a leading cause of death among young children, with the majority of diarrhea deaths occurring in low- and middle-income countries. Childhood diarrhea caused by a type of bacteria called "Shigella" is responsible for an estimated 60,000 deaths each year and may cause particularly severe illness among children. Currently, there are several promising vaccines to prevent Shigella diarrhea in development, but key information is still needed to inform future vaccine studies. The purpose of this study, titled Enterics for Global Health (or the "EFGH"), is to determine the number and rate of new cases of Shigella diarrhea among children 6 to 35 months of age presenting to health facilities with diarrhea or dysentery. Over a two-year period, the EFGH study will enroll 1,400 children from each of the seven countries: Peru, Pakistan, Bangladesh, Mali, Malawi, Kenya, and The Gambia (9,800 children total).

Conditions

Sponsors & Collaborators

  • Aga Khan University

    collaborator OTHER
  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER
  • University of Maryland, Baltimore

    collaborator OTHER
  • University of Virginia

    collaborator OTHER
  • Asociacion Benefica Prisma

    collaborator OTHER
  • Medical Research Council Unit, The Gambia

    collaborator OTHER
  • Kenya Medical Research Institute

    collaborator OTHER
  • Center for Vaccine Development - Mali

    collaborator OTHER
  • Malawi-Liverpool-Wellcome Trust Clinical Research Programme

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • University of Washington

    lead OTHER

Principal Investigators

  • Patricia B Pavlinac, PhD · University of Washington

Eligibility

Min Age
6 Months
Max Age
35 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-25
Primary Completion
2024-08-17
Completion
2025-04-30

Countries

  • Bangladesh
  • Kenya
  • Malawi
  • Mali
  • Pakistan
  • Peru
  • The Gambia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06047821 on ClinicalTrials.gov